High level of COP1 expression is associated with poor prognosis in primary gastric cancer

International Journal of Biological Sciences

Volumn 8, Issue 8, 2012, Pages 1168-1177

  Li, Yuan fang ^a   Wang, Dan dan ^a   Zhao, Bai wei ^a   Wang, Wei ^a   Huang, Chun yu ^a   Chen, Yong ming ^a   Zheng, Yan ^a   Keshari, Rajiv Prasad ^a   Xia, Jian chuan ^a   Zhou, Zhi wei ^a  

^a SUN YAT SEN UNIVERSITY CANCER CENTER   (China)

Author keywords

COP1; Expression; Gastric cancer; Immunohistochemistry; Prognosis

Indexed keywords

PRIMER DNA; RFWD2 PROTEIN, HUMAN; UBIQUITIN PROTEIN LIGASE;

ARTICLE; COMPARATIVE STUDY; GENE EXPRESSION REGULATION; GENETICS; HUMAN; IMMUNOHISTOCHEMISTRY; KAPLAN MEIER METHOD; METABOLISM; PHYSIOLOGY; PROGNOSIS; REAL TIME POLYMERASE CHAIN REACTION; REGRESSION ANALYSIS; STOMACH TUMOR; WESTERN BLOTTING;

BLOTTING, WESTERN; DNA PRIMERS; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; IMMUNOHISTOCHEMISTRY; KAPLAN-MEIER ESTIMATE; PROGNOSIS; REAL-TIME POLYMERASE CHAIN REACTION; REGRESSION ANALYSIS; STOMACH NEOPLASMS; UBIQUITIN-PROTEIN LIGASES;

EID: 84867545561     PISSN: 14492288     EISSN: None     Source Type: Journal    
DOI: 10.7150/ijbs.4778     Document Type: Article

References (28)

1. Parkin DM. International variation. Oncogene. 2004; 23: 6329-40.
2. Jemal A, Siegel R, Ward E, et al. Cancer statistics. CA Cancer J Clin. 2009; 59: 225-49.
3. Nobili S, Bruno L, Landini I, et al. Genomic and genetic alterations influence the progression of gastric cancer. World J Gastroenterol. 2011; 17: 290-9.
4. [Internet] Ajani JA, Barthel JS, Bekaii-Saab T. NCCN Clinical Practice Guidelines in Oncology. Gastric cancer, v.2.2010. www.nccn.org.
5. Chen CN, Lin JJ, Chen JJ, et al. Gene expression profile predicts patient survival of gastric cancer after surgical resection. J Clin Oncol. 2005; 23: 7286-95.
6. Dornan D, Shimizu H, Mah A, et al. ATM engages autodegradation of the E3 ubiquitin ligase COP1 after DNA damage. Science. 2006; 313: 1122-8.
7. Yasui W, Oue N, Aung PP, et al. Molecularpathological prognostic factors of gastric cancer: a review. Gastric Cancer. 2005; 8: 86-94.
8. Lee HS, Cho SB, Lee HE, et al. Protein expression profiling and molecu-lar classification of gastric cancer by the tissue array method. Clin Cancer Res. 2007; 13: 4154-63.
9. Oue N, Hamai Y, Mitani Y, et al. Gene expression profile of gastric carcinoma: identification of genes and tags potentially involved in inva-sion, metastasis, and carcinogenesis by serial analysis of gene expression. Cancer Res. 2004; 64: 2397-405.
10. Hippo Y, Taniguchi H, Tsutsumi S, et al. Global gene expression analysis of gastric cancer by oligonucleotide microarrays. Cancer Res. 2002; 62: 233-40.
11. Bianchi E, Denti S, Catena R, et al. Characterization of human constitu-tive photomorphogenesis protein 1, a RING finger ubiquitin ligase that interacts with Jun transcription factors and modulates their transcrip-tional activity. J Biol Chem. 2003; 278: 19682-90.
12. Kato S, Ding J, Pisck E, et al. COP1 functions as a FoxO1 ubiquitin E3 ligase to regulate FoxO1-mediated gene expression. J Biol Chem. 2008; 283: 35464-73.
13. Wang L, He G, Zhang P, et al. Interplay between MDM2, MDMX, Pirh2 and COP1: the negative regulators of p53. Mol Biol Rep. 2011; 38: 229-36.
14. Dornan D, Wertz I, Shimizu H, et al. The ubiquitin ligase COP1 is a critical negative regulator of p53. Nature. 2004; 429: 86-92.
15. Dornan D, Bheddah S, Newton K, et al. COP1, the Negative Regulator of p53, Is Overexpressed in Breast and Ovarian Adenocarcinomas. Cancer Res. 2004; 64: 7226-30.
16. Lee YH, Andersen JB, Song HT, et al. Definition of ubiquitination mod-ulator COP1 as a novel therapeutic target in human hepatocellular car-cinoma. Cancer Res. 2010; 70: 8264-9.
17. Vitari AC, Leong KG, Newton K, et al. COP1 is a tumour suppressor that causes degradation of ETS transcription factors. Nature. 2011; 474: 403-6.
18. Migliorini D, Bogaerts S, Defever D, et al. Cop1 constitutively regulates c-Jun protein stability and functions as a tumor suppressor in mice. J Clin Invest. 2011; 121: 1329-43.
19. Su CH, Zhao R, Zhang F, et al. 14-3-3σ exerts tumor-suppressor activity mediated by regulation of COP1 stability. Cancer Res. 2011; 71: 884-94.
20. Baert JL, Monte D, Verreman K, et al. The E3 ubiquitin ligase complex component COP1 regulates PEA3 group member stability and tran-scriptional activity. Oncogene. 2010; 29: 1810-20.
21. Choi HH, Gully C, Su CH, et al. COP9 signalosome subunit 6 stabilizes COP1, which functions as an E3 ubiquitin ligase for 14-3-3σ. Oncogene. 2011; 30: 4791-801.
22. Stanley R. Hamilton, Lauri A. Aaltonen. Pathology and genetics of tumours of the digestive system. New York, USA: Oxford University Press; 2001.
23. Xu LZ, Yang WT. Immunohistochemistry reaction results judgement standard. China Oncology. 1996; 6: 229-31.
24. Jemal A, Bray F, Center MM, et al. Global cancer statistics. CA Cancer J Clin. 2011; 61: 69-90.
25. Hartgrink HH, Jansen EP, van Grieken NC, et al. Gastric cancer. Lancet. 2009; 374: 477-90.
26. Jin S & Levine AJ. The p53 functional circuit. J. Cell Sci. 2001; 114: 4139-40.
27. Hollstein M, Sidransky D, Vogelstein B, et al. p53 mutations in human cancers. Science. 1991; 253: 49-53.
28. Marine JC. Spotlight on the role of COP1 in tumorigenesis. Nat Rev Cancer. 2012; 12: 455-64.